117 related articles for article (PubMed ID: 38872163)
1. Assessment of bacteriocin production by clinical Pseudomonas aeruginosa isolates and their potential as therapeutic agents.
Charkhian H; Soleimannezhadbari E; Bodaqlouei A; Lotfollahi L; Lotfi H; Yousefi N; Shojadel E; Gholinejad Z
Microb Cell Fact; 2024 Jun; 23(1):175. PubMed ID: 38872163
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional analysis of a bacteriocin, pyocin S6, with ribonuclease activity from a Pseudomonas aeruginosa cystic fibrosis clinical isolate.
Dingemans J; Ghequire MG; Craggs M; De Mot R; Cornelis P
Microbiologyopen; 2016 Jun; 5(3):413-23. PubMed ID: 26860427
[TBL] [Abstract][Full Text] [Related]
3. Heterogenous Susceptibility to R-Pyocins in Populations of Pseudomonas aeruginosa Sourced from Cystic Fibrosis Lungs.
Mei M; Thomas J; Diggle SP
mBio; 2021 May; 12(3):. PubMed ID: 33947755
[TBL] [Abstract][Full Text] [Related]
4. A Colicin M-Type Bacteriocin from Pseudomonas aeruginosa Targeting the HxuC Heme Receptor Requires a Novel Immunity Partner.
Ghequire MGK; Öztürk B
Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980560
[TBL] [Abstract][Full Text] [Related]
5. F-Type Pyocins Are Diverse Noncontractile Phage Tail-Like Weapons for Killing
Saha S; Ojobor CD; Li ASC; Mackinnon E; North OI; Bondy-Denomy J; Lam JS; Ensminger AW; Maxwell KL; Davidson AR
J Bacteriol; 2023 Jun; 205(6):e0002923. PubMed ID: 37260386
[TBL] [Abstract][Full Text] [Related]
6. Characterization of R-pyocin activity against Gram-positive pathogens for the first time with special focus on Staphylococcus aureus.
Mohamed AA; Elshawadfy AM; Amin G; Askora A
J Appl Microbiol; 2021 Dec; 131(6):2780-2792. PubMed ID: 33977611
[TBL] [Abstract][Full Text] [Related]
7. Targeted Killing of Pseudomonas aeruginosa by Pyocin G Occurs via the Hemin Transporter Hur.
Atanaskovic I; Mosbahi K; Sharp C; Housden NG; Kaminska R; Walker D; Kleanthous C
J Mol Biol; 2020 Jun; 432(13):3869-3880. PubMed ID: 32339530
[TBL] [Abstract][Full Text] [Related]
8. O serotype-independent susceptibility of Pseudomonas aeruginosa to lectin-like pyocins.
Ghequire MG; Dingemans J; Pirnay JP; De Vos D; Cornelis P; De Mot R
Microbiologyopen; 2014 Dec; 3(6):875-84. PubMed ID: 25224846
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of lipopolysaccharide mutants and R2-pyocin susceptible variants in
Mei M; Pheng P; Kurzeja-Edwards D; Diggle SP
Microbiol Spectr; 2023 Dec; 11(6):e0177323. PubMed ID: 37877708
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa Soluble Pyocins as Antibacterial Weapons.
Cornelis P; Dingemans J; Baysse C
Methods Mol Biol; 2024; 2721():125-136. PubMed ID: 37819519
[TBL] [Abstract][Full Text] [Related]
11. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin.
Rampling A; Whitby JL; Wildy P
J Med Microbiol; 1975 Nov; 8(4):531-41. PubMed ID: 812999
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide as shield and receptor for R-pyocin-mediated killing in Pseudomonas aeruginosa.
Köhler T; Donner V; van Delden C
J Bacteriol; 2010 Apr; 192(7):1921-8. PubMed ID: 20118263
[TBL] [Abstract][Full Text] [Related]
13. Impact of FiuA Outer Membrane Receptor Polymorphism on the Resistance of
Latino L; Patin D; Chérier D; Touzé T; Pourcel C; Barreteau H; Mengin-Lecreulx D
J Bacteriol; 2019 Jul; 201(13):. PubMed ID: 30988031
[TBL] [Abstract][Full Text] [Related]
14. Bacteriocin-mediated competition in cystic fibrosis lung infections.
Ghoul M; West SA; Johansen HK; Molin S; Harrison OB; Maiden MC; Jelsbak L; Bruce JB; Griffin AS
Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26311664
[TBL] [Abstract][Full Text] [Related]
15. Fis Contributes to Resistance of Pseudomonas aeruginosa to Ciprofloxacin by Regulating Pyocin Synthesis.
Long Y; Fu W; Wang S; Deng X; Jin Y; Bai F; Cheng Z; Wu W
J Bacteriol; 2020 May; 202(11):. PubMed ID: 32205461
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa.
Morse SA; Vaughan P; Johnson D; Iglewski BH
Antimicrob Agents Chemother; 1976 Aug; 10(2):354-62. PubMed ID: 825024
[TBL] [Abstract][Full Text] [Related]
17. Competition in Biofilms between Cystic Fibrosis Isolates of
Oluyombo O; Penfold CN; Diggle SP
mBio; 2019 Jan; 10(1):. PubMed ID: 30696740
[No Abstract] [Full Text] [Related]
18. SOS-Independent Pyocin Production in P. aeruginosa Is Induced by XerC Recombinase Deficiency.
Baggett NS; Bronson AS; Cabeen MT
mBio; 2021 Dec; 12(6):e0289321. PubMed ID: 34809462
[TBL] [Abstract][Full Text] [Related]
19. [Pyocin production by bacillus pyocyaneus and sensitivity of strains of different origin to them].
Kurnosova LM; Sukhodol'skaia AE; Suvorova TI; Faustova VA
Zh Mikrobiol Epidemiol Immunobiol; 1980 Jul; (7):8-13. PubMed ID: 6776722
[TBL] [Abstract][Full Text] [Related]
20. Pyocin S5 Import into Pseudomonas aeruginosa Reveals a Generic Mode of Bacteriocin Transport.
Behrens HM; Lowe ED; Gault J; Housden NG; Kaminska R; Weber TM; Thompson CMA; Mislin GLA; Schalk IJ; Walker D; Robinson CV; Kleanthous C
mBio; 2020 Mar; 11(2):. PubMed ID: 32156826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
